Home LiteratureArticle Details
PMID: 3324960 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Cryptic tetracycline resistance determinant (class F) from Bacteroides fragilis mediates resistance in Escherichia coli by actively reducing tetracycline accumulation.

Antimicrobial agents and chemotherapy ·Vol. 31 ·No. 11 ·1987-11-00 ·Pages 1739-43

Park BH, Hendricks M, Malamy MH, Tally FP, Levy SB

Abstract

Escherichia coli bearing a cryptic tetracycline resistance determinant from Bacteroides fragilis expressed low-level constitutive resistance to tetracycline under aerobic, but not anaerobic, growth conditions and accumulated less tetracycline aerobically than did isogenic susceptible cells. This decreased uptake was energy dependent and reversible by increased concentrations of tetracycline, suggesting a saturable carrier-mediated active efflux mechanism. Decreased uptake was not seen when the cells were grown and assayed anaerobically. Other tetracycline resistance determinants (classes A to E) isolated from gram-negative enteric bacteria expressed resistance and generated active efflux of tetracycline under anaerobic as well as aerobic conditions. When the Bacteroides determinant was placed in the same cell with any of the class A to E tetracycline resistance determinants, there was an increase in resistance under aerobic conditions of as much as 48% more than was projected by adding the resistances expressed by the determinants individually. In cells bearing the class A determinant together with the Bacteroides determinant, saturation of the active efflux system required over twofold more exogenous tetracycline than did cells bearing the class A determinant alone. We have designated this new tetracycline resistance determinant class F.

MeSH Terms
Bacteroides fragilis/drug effects,genetics Escherichia coli/drug effects,metabolism Plasmids Tetracycline/pharmacokinetics Tetracycline Resistance/genetics
Chemicals
Tetracycline
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Park B H
Department of Molecular Biology, Tufts University School of Medicine, Boston, Massachusetts 02111.
Hendricks M
Malamy M H
Tally F P
Levy S B
References (20)
20 references, click to expand
  1. High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant.
    Antimicrob Agents Chemother. 1986 Nov;30(5):664-70 PMID: 3099640
  2. Dissemination of the tetM tetracycline resistance determinant to Ureaplasma urealyticum.
    Antimicrob Agents Chemother. 1986 Feb;29(2):350-2 PMID: 3521481
  3. Heterogeneity of tetracycline resistance determinants.
    Plasmid. 1980 Mar;3(2):99-108 PMID: 6927764
  4. A new tetracycline-resistance determinant, class E, isolated from Enterobacteriaceae.
    Gene. 1986;50(1-3):111-7 PMID: 3034728
  5. Homology of a transferable tetracycline resistance determinant of Clostridium difficile with Streptococcus (Enterococcus) faecalis transposon Tn916.
    Antimicrob Agents Chemother. 1987 Jul;31(7):1033-8 PMID: 2821887
  6. Energy-dependent efflux mediated by class L (tetL) tetracycline resistance determinant from streptococci.
    Antimicrob Agents Chemother. 1987 Oct;31(10):1648-50 PMID: 3324958
  7. Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli.
    Proc Natl Acad Sci U S A. 1980 Jul;77(7):3974-7 PMID: 7001450
  8. Tetracycline transport in Bacteroides fragilis.
    Antimicrob Agents Chemother. 1980 Oct;18(4):502-5 PMID: 7447414
  9. Heterogeneity of tetracycline resistance determinants in Streptococcus.
    J Bacteriol. 1982 Mar;149(3):995-1004 PMID: 6801018
  10. Two complementation groups mediate tetracycline resistance determined by Tn10.
    J Bacteriol. 1982 Jul;151(1):209-15 PMID: 6282805
  11. Transport of the lipophilic analog minocycline differs from that of tetracycline in susceptible and resistant Escherichia coli strains.
    Antimicrob Agents Chemother. 1982 Nov;22(5):791-9 PMID: 6758689
  12. The tetracycline resistance determinants of RP1 and Tn1721: nucleotide sequence analysis.
    Nucleic Acids Res. 1983 Sep 10;11(17):6089-105 PMID: 6310527
  13. Frequency of tetracycline resistance determinant classes among lactose-fermenting coliforms.
    Antimicrob Agents Chemother. 1983 Dec;24(6):835-40 PMID: 6660856
  14. Homogeneity of transferable tetracycline-resistance determinants in Haemophilus species.
    J Infect Dis. 1984 Jun;149(6):1028-9 PMID: 6330236
  15. Expression in Escherichia coli of cryptic tetracycline resistance genes from bacteroides R plasmids.
    Plasmid. 1984 May;11(3):248-52 PMID: 6379711
  16. Heterologous repressor-operator recognition among four classes of tetracycline resistance determinants.
    J Bacteriol. 1985 Jan;161(1):326-32 PMID: 3881391
  17. Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences.
    Antimicrob Agents Chemother. 1985 Jul;28(1):141-3 PMID: 2994555
  18. Tn4400, a compound transposon isolated from Bacteroides fragilis, functions in Escherichia coli.
    J Bacteriol. 1985 Dec;164(3):1248-55 PMID: 2999075
  19. Streptococcal tetracycline resistance mediated at the level of protein synthesis.
    J Bacteriol. 1986 Feb;165(2):564-9 PMID: 3080409
  20. Tetracycline resistance and tetM in pathogenic urogenital bacteria.
    Antimicrob Agents Chemother. 1986 Nov;30(5):810-2 PMID: 3800360
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1987-11-00
Pages
1739-43
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC175031
Subset
IM
Grants
NIAID NIH HHS · AI16756 · United States
NIAID NIH HHS · AI19497 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com